Published in Biull Eksp Biol Med on January 01, 1998
[Modification of a mutation process in human cells]. Vestn Ross Akad Med Nauk (2001) 1.00
Oxygen radical-mediated mutagenic effect of asbestos on human lymphocytes: suppression by oxygen radical scavengers. Mutat Res (1992) 0.98
[Free radicals and reduced DNA damage in repair-defective human cells]. Dokl Akad Nauk (1999) 0.89
[Methylnitrosourea as challenge mutagen in assessment of the DNA mismatch repair (MMR) activity: association with some types of cancer]. Genetika (2008) 0.82
[Prevalence of mental disorders in SLE patients: correlations with the disease activity and comorbid chronic conditions]. Ter Arkh (2009) 0.80
[Synovial membrane in the early stage of rheumatoid arthritis: clinico-morphological comparisons]. Ter Arkh (2003) 0.78
[Corticosteroid therapy and aseptic bone necrosis in patients with rheumatoid arthritis]. Ter Arkh (1995) 0.78
[Clastogenic activity of dietary sugar substitutes]. Vopr Med Khim (1996) 0.78
Effect of Betula bark extract on spontaneous and induced mutagenesis in mice. Bull Exp Biol Med (2004) 0.77
[Antimutagenic and antiteratogenic properties of afobazole]. Eksp Klin Farmakol (2009) 0.77
Study of anti-ischemic effect of afobazole in experimental myocardial infarction. Bull Exp Biol Med (2011) 0.77
[Colorectal cancer: mismatch repair deficiency, genomic instability, tolerance to apoptosis and assessment of risk]. Vopr Onkol (2005) 0.77
[The magnitude of fatigue and its association with depression, pain, and inflammatory activity in rheumatoid arthritis]. Ter Arkh (2013) 0.77
Total antioxidant capacity of blood plasma from healthy donors receiving vitamin and mineral complex. Bull Exp Biol Med (2004) 0.77
Verapamil contributes to the clastogenic effects of acrylamide, cyclophosphamide, and dioxidine on somatic cells of BALB/C and C57BL/6 mice. Mutat Res (1999) 0.77
[Prospects for the assessment of cardiac rhythm variability in patients with rheumatoid arthritis and systemic lupus erythematosus]. Vestn Ross Akad Med Nauk (2010) 0.77
Impaired prenatal development and glycemic status in the offspring of rats with experimental streptozotocin-induced diabetes and their correction with afobazole. Bull Exp Biol Med (2014) 0.76
Assessment of DNA damage in human bone marrow cells and multipotent mesenchymal stromal cells. Bull Exp Biol Med (2011) 0.76
[Cognitive impairment and anxiety-depressive disorders in patients with rheumatoid arthritis]. Zh Nevrol Psikhiatr Im S S Korsakova (2012) 0.76
Correcting effect of ladasten on variations in the subpopulation composition of T lymphocytes in C57BL/6 mice on the experimental model of an anxious-depressive state. Bull Exp Biol Med (2014) 0.76
[Human pathologies associated with mutations of mitochondrial genome]. Patol Fiziol Eksp Ter (2012) 0.76
Comparative investigation of anticlastogenic effects in cell cultures of healthy donors and patients with nettle-rash. Mutat Res (1994) 0.76
[Mutagenic and antimutagenic properties of bemitil]. Biull Eksp Biol Med (1986) 0.76
Eosinophilic fasciitis. Review and report of six cases. Scand J Rheumatol (1979) 0.76
[The mutagenic action of the dust of natural zeolites and chrysotile asbestos]. Eksp Onkol (1990) 0.75
[Remote effects in the mutagenic action of chrysotile asbestos and zeolite dusts in vivo]. Biull Eksp Biol Med (1993) 0.75
[Corpuscular mutagenesis and its prevention]. Vestn Ross Akad Med Nauk (1995) 0.75
In vive study of dihydroquercetin genotoxicity. Bull Exp Biol Med (2008) 0.75
[Diagnostic possibilities of a test of blood neutrophil damage in various forms of yersiniosis in man]. Vestn Akad Med Nauk SSSR (1989) 0.75
[Antibodies to extractable nuclear antigens in rheumatic diseases]. Ter Arkh (1980) 0.75
[Sedimentation of alkaline lysates of irradiated rat bone marrow cells]. Radiobiologiia (1984) 0.75
[Binding of SSB-protein from Ehrlich ascites carcinoma cells with DNA and polyribonucleotides]. Mol Biol (Mosk) (1991) 0.75
[Combined syndromes of diffuse connective tissue diseases]. Vopr Revm (1978) 0.75
[Formation and repair of DNA breaks in bone marrow cells of the irradiated rat]. Radiobiologiia (1984) 0.75
[The formation and repair of DNA breaks in subpopulations of irradiated rat bone marrow cells]. Radiobiologiia (1989) 0.75
[The long-term parenteral use of cyclophosphane in treating patients with systemic lupus erythematosus and central nervous system involvement]. Ter Arkh (1995) 0.75
[Damage and functional recovery of the mouse retina after exposure to ionizing radiation and methylnitrosourea]. Radiats Biol Radioecol (2015) 0.75
[Treatment of systemic lupus erythematosus]. Klin Med (Mosk) (1985) 0.75
[Hemoperfusion through activated charcoal in the complex treatment of systemic lupus erythematosus]. Ter Arkh (1981) 0.75
[The adaptive reaction of the blood lymphocytes in persons subjected to chronic radiation exposure at low doses]. Radiats Biol Radioecol (1995) 0.75
[The microelectrophoresis of the DNA in individual intact and gamma-irradiated thymocytes]. Tsitologiia (1991) 0.75
[Radiation preconditioning of mouse retina results in tolerance to MNU-induced degeneration and stimulates retinal recovery]. Tsitologiia (2015) 0.75
[Results of long-term observations of systemic lupus erythematosus patients]. Ter Arkh (1968) 0.75
[Circulating immune complexes and clinico-immunologic subtypes of systemic lupus erythematosus. II]. Ter Arkh (1989) 0.75
[Active forms of oxygen and pathogenesis of rheumatoid arthritis and systemic lupus erythematosus]. Vestn Ross Akad Med Nauk (1996) 0.75
[Cerebral vasculitis complicated with ruptured aneurysm of the basilar artery in a patient with systemic lupus erythematosus]. Klin Med (Mosk) (1993) 0.75
[Quantitative characteristic of circulating immune complexes in patients with lupus erythematosus and central nervous system disorders]. Klin Med (Mosk) (1991) 0.75
[Effectiveness of DNA repair and expression of MLH1, MSH2 and FASR in lymphocytes of patients with chemotherapy-responsive, disseminated cutaneous melanoma]. Vopr Onkol (2011) 0.75
[Diagnostic criteria of systemic lupus erythematosus]. Sov Med (1980) 0.75
[Study of rheumatic diseases and international cooperation]. Vopr Revm (1979) 0.75
[Systemic lupus erythematosus with involvement of the central nervous system]. Klin Med (Mosk) (1989) 0.75
[Cellular markers based on DNA damage and repair (BER, MMR), expression of MLHI, MSH2, FasR, and cell death of lymphocytes as predictive parameters for clinical response to chemotherapy of melanoma]. Tsitologiia (2011) 0.75
[Mixed connective tissue disease]. Ter Arkh (1982) 0.75
[Effect of cytotoxic immunosuppressive agents on the level of urinary seromucoids and cathepsins in lupus nephritis]. Ter Arkh (1980) 0.75
[Intravenous administration of high doses (pulse therapy) of methylprednisolone in lupus nephritis]. Ter Arkh (1983) 0.75
[Nephropathy in a patient with systemic scleroderma treated with D-penicillamine]. Ter Arkh (1980) 0.75
[Soviet-American cooperation on the problem of arthritides]. Vopr Revm (1980) 0.75
[Mechanisms of radioresistance in terminally differentiated cells of mature retina]. Tsitologiia (2012) 0.75
[Mismatch repair (MMR) efficiency and MSH2 gene mutation in human colorectal carcinoma cell line COLO320HSR]. Genetika (2007) 0.75
[An evaluation of the results of the long-term treatment of rheumatoid arthritis patients with gold salts, aminoquinoline preparations and nonsteroidal anti-inflammatory preparations]. Ter Arkh (1997) 0.75
[Basic methods of treatment of and individual programs for patients with systemic lupus erythematosus]. Klin Med (Mosk) (2000) 0.75
[Comparative study of DNA-repair ability of lymphocytes from systemic lupus erythematosus and rheumatoid arthritis patients]. Genetika (1997) 0.75
[Effect of exogenous interferon on the viability of SOTs cells]. Radiobiologiia (1977) 0.75
[The results of the dynamic observation of patients with reactive Yersinia arthritis]. Ter Arkh (1991) 0.75
[Immunomorphological changes in the skin of patients with systemic lupus erythematosus and the effect of cytostatic therapy]. Ter Arkh (1981) 0.75
[Dynamic studies of skin microcirculation during treatment of lupus nephritis with cytostatic immunosuppressants]. Ter Arkh (1980) 0.75
[Diffuse eosinophilic fasciitis]. Ter Arkh (1978) 0.75
[Circulating immune complexes (PEG tests) in systemic lupus erythematosus]. Ter Arkh (1982) 0.75
[Morphological and immunohistochemical changes in the kidneys and skin in systemic lupus erythematosus during the course of treatment]. Revmatologiia (Mosk) (1983) 0.75
[The rheumatic complications of pseudotuberculosis in a newly arrived population in Siberia]. Ter Arkh (1991) 0.75
[Natural cytotoxicity in systemic lupus erythematosus patients]. Ter Arkh (1984) 0.75
[Basic principles of differentiated therapy of patients with "major" collagenoses]. Vopr Revm (1970) 0.75
[Retina radioresistance: whole-body exposure of mice to gamma-irradiation induces the retina DNA damage, accumulation of p53 protein followed by DNA repair rather than the apoptosis]. Radiats Biol Radioecol (2009) 0.75
[Present problems of neuroimmunology]. Vestn Ross Akad Med Nauk (1994) 0.75
[Diagnosis of lesions of the central nervous system in patients with systemic lupus erythematosus]. Revmatologiia (Mosk) (1992) 0.75
[Clinico-immunologic characteristics of complicated and uncomplicated yersiniosis]. Vestn Akad Med Nauk SSSR (1989) 0.75
[Clinico-genetic associations in systemic lupus erythematosus]. Ter Arkh (1981) 0.75
[Controlled trial of cyclophosphamide, azathioprine and chlorambucil in lupus nephritis (the double-blind method)]. Vopr Revm (1982) 0.75
[Inhibitory effect of sera from patients with rheumatic diseases on EA-rosette formation]. Ter Arkh (1983) 0.75
[Lesions of the central nervous system in systemic lupus erythematosus in the computerized-tomographic image]. Klin Med (Mosk) (1989) 0.75
[An assessment of tissue microcirculation in patients with aseptic femur head necrosis in rheumatoid arthritis]. Ter Arkh (1994) 0.75
[Diclonate P in rheumatoid arthritis]. Ter Arkh (1994) 0.75
[Study of DNA damage and heterogeneity of cells by a gel microelectrophoresis method]. Biofizika (1995) 0.75
[The Tauredon treatment of rheumatoid arthritis patients: its efficacy and tolerance when used long term]. Ter Arkh (1996) 0.75
[Scientific bases of medical examinations of patients with rheumatic diseases]. Vestn Ross Akad Med Nauk (1998) 0.75
[Flurbiprofen: pharmacological characteristics and clinical effectiveness]. Klin Med (Mosk) (1998) 0.75
[Isolation and characteristics of single-stranded DNA-binding protein (SSB-protein) from Ehrlich ascites carcinoma cells]. Biokhimiia (1988) 0.75
[Induction of double-strand DNA breaks in rat bone marrow cells by X-radiation]. Radiobiologiia (1984) 0.75
[The regularities of the induction of DNA double strand breaks and DNA repair in human lymphocytes after irradiation by accelerated heavy ions with different energy]. Radiats Biol Radioecol (2009) 0.75
[Materials on approbation of diagnostic criteria in disseminated connective tissue diseases]. Ter Arkh (1978) 0.75
[The clinico-immunological characteristics of central nervous system involvement in systemic lupus erythematosus: the relationship with antibodies to cardiolipin]. Ter Arkh (1992) 0.75
[Ultra-high (shock) doses of methylprednisolone in lupus nephritis]. Ter Arkh (1980) 0.75
[Study of the peripheral blood lymphocytes in systemic lupus erythematosus of different degree of activity]. Ter Arkh (1978) 0.75
[Genetic markers of melanoma]. Genetika (2010) 0.75
[Effect of hemosorption on the course of autoimmune diseases with predominant involvement of the skin]. Klin Med (Mosk) (1982) 0.75
[The effect of bemetil on the production of DNA antibodies in patients with systemic lupus erythematosus]. Eksp Klin Farmakol (1999) 0.75